Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds
Status:
Completed
Trial end date:
2023-02-08
Target enrollment:
Participant gender:
Summary
In this research, the patients with chronic wounds accompanied by pain were treated by
injecting freshly manufactured tissue permeable hyaluronan fragment HA35 into the tissue
under the heath skin immediately surrounding the chronic wounds.